as living with HIV on treatment and ensure that 90% of people on treatment have sustained viral load suppression. In contrast to the earlier policy of providing free for only those people with CD4 count <500cells/mm 3 , the new policy envisages provision free ART for every person living with HIV and AIDS as per new UNAIDS recommendations. 2 Apart from documented benefits for the infected person, ART has been proved to significantly reduce the probability of vertical transmission and even transmission of HIV by the sexual route by suppressing plasma HIV-RNA concentration to undetectable levels. Many studies have reported that expansion of access to ART results in decline of aggregate HIV-RNA measures and in turn in reduced incidence of HIV at the population level. [3] [4] [5] [6] [7] [8] But as in many countries, the National AIDS Control Programme (NACP) in India has identified crucial gaps in case of detection as about 28% of the people with HIV remain undetected till 2016.
Analysis of programme data has indicated that there is 33-43% gap in the testing of key population around 90% gap in the testing of bridge population, around 65% gap in the testing of STI clients, 23% in TB patients, 45% in pregnant women and 64% in partners of PLHIV. 2 Published literature provides extensive evidence that delayed initiation of combination antiretroviral therapy (ART) in HIV infection increases the risk of poor treatment outcomes, morbidity and mortality. 3, 9, 10 Despite substantial evidence supporting the benefits of early initiation of ART, HIV continues to be diagnosed and treated later than contemporary guidelines recommended. [11] [12] [13] Some of the recent large-scale reviews by Gabillard D et al, and Gupta A et al, have highlighted substantial mortality even after the initiation of ART in low and middle-income countries. 14, 15 Delay in diagnosis of HIV and lower CD4 counts at the time of diagnosis is considered as a major reason for this phenomenon. Considering the above-mentioned facts, analysis of CD4 counts and their correlation with the presence of opportunistic infections in newly diagnosed HIV infections may provide vital inputs to the policymakers. But the availability of studies on Indian population is very scarce and not many studies have explored the status of CD4 count and factors associated with the low CD4 count in an Indian setting.
The critical analysis of the profile of the cases with the low CD4 count at diagnosis may help in identifying high risk groups for delayed diagnosis and take appropriate measures to improve the same. The study assessed the profile of newly diagnosed HIV cases, risk behaviors and the reason for testing in a single Integrated counseling and testing center. To assess the status of the CD4 count at diagnosis among newly diagnosed HIV infections in a single Integrated counseling and testing center and analyze the factors, associated with low CD4 count among the study population.
METHODS
The study was a cross sectional observational study conducted in the Department of Dermatology, Venereology and Leprosy, NRI Medical College and General Hospital. The study population included all the subjects who were newly diagnosed with HIV infection in a single integrated counseling and testing center (ICTC) and ART centre under national Aids Control Programme (NACP) affiliated to the study setting.
All the newly diagnosed HIV cases in the study setting between January 2017 to December 2017 were included in the study. To be included in the study, the participants must be adults aged 18years or above, tested for HIV status and labeled as HIV positive as per the diagnostic guidelines of the national AIDS control programme, not previously tested or treated for HIV in the past and willing to be tested for the CD4 count.
All the relevant data was retrieved from the official records maintained as part of the routine implementation of the programme. Appropriate pre-test counseling was provided as per the standard national guidelines for HIV testing under NACO. HIV was diagnosed by serological tests (antigen and antibody detection) on appropriate specimen serum/plasma/whole blood is used, whereas for. For CD4 enumeration, 3milliliters of blood was collected in a K2/K3 EDTA evacuated tube. Once collected, the blood specimens were processed immediately within a maximum of 48hours. During this time, the blood specimen was kept at ambient temperature and not in the refrigerator. The CD4 enumeration was done as per the national guidelines for enumeration of CD4 2015 guidelines issued by national aids control organization (NACO), India. The method involved flow cytometry method, using single platform technology. 16 The study was approved by the institutional human ethics committee. Informed written consent was obtained from all participants. Strict confidentiality of the study participants was maintained throughout the reporting of the study findings. The key outcome parameters included the CD4 count at the time of diagnosis. The other variables of interest considered for analysis include demographic parameters of the participants including their level of education and occupation, the particulars regarding the participant's sexual preferences and sexual behavior, knowledge related to various aspects of HIV/AIDS and the clinical presentation at the time of diagnosis.
Baseline demographic and clinical characteristics of participants were summarized using mean and standard deviation for continuous variables and frequencies and proportions for categorical variables. The association between various demographic, HIV knowledge related factors and low CD4 count (<200) was assessed by univariate logistic regression analysis. Unadjusted odds ratio along with its 95% Confidence interval and P value was presented. A p value <0.05 was considered as statistically significant. Data analysis was performed by IBM SPSS version 23.
RESULTS
A total 125 people were included in the final analysis. The mean age was 36.56±10.17 in the study population. The proportion of females was slightly higher (55.2% vs 44%) in the study and there was only one transgender subject. The educational standard of the study population was poor as 18.5% of the reported no formal education and another 47.6% reported have completed only the primary school. The proportion of the unemployed population was 42.1% and the majority of the study population were married (69.60%). Majority of the study population (24.80%) were housewives. Table  4 ).
The factors which had shown a positive association with low CD4 count (<200) were male gender, poor educational status, working for population, single/ divorced, people with more sexual partners and people with poor knowledge regarding HIV/AIDS. But none of the associations were statistically significant (Table 5) . 
DISCUSSION
Highly Active Antiretroviral therapy (HAART) has been proved not only to have a significant positive impact on the morbidity and mortality of the HIV affected individual but also significantly reduces the disease transmission. CD4 count at the diagnosis and initiation of HAART is found to be a key determinant of the success of HAART. Siegfried N et al, in their systematic review, they have reported that, a statistically significant reduction in death when starting ART at higher CD4 counts. 17 Risk of death was reduced by 74% (RR=0.26; 95% CI: 0.11, 0.62; P=0.002). Risk of tuberculosis was reduced by 50% in the groups starting ART early. They have reported an evidence of moderate quality that initiating ART at CD4 levels higher than 200 or 250cells/microL reduces mortality rates in asymptomatic, ART-naive, HIV-infected people. Anglaret X et al, have also reported ART initiation at entry into care would improve long-term survival of patients with high CD4(+) T-cell counts, provided higher treatment adherence. 18 So, early diagnosis of the disease, at the asymptomatic stage with relatively higher CD4 counts is vital for maximizing its benefits, both at individual and community level. So, voluntary counseling and testing are vital in this regard but in the current study, only 3 (2.40%) of newly diagnosed HIV subjects were diagnosed by voluntary counseling and testing. The majority were diagnosed when presented with symptomatic conditions attributed to HIV infection (34.70%) or with AIDS-defining 35.50%). Similar to the current study, a study done in Barbados by Kilaru KR et al, have reported majority (57.6%) of the newly diagnosed HIV patients to be presenting with HIV/AIDSrelated illness as in the current study. 19 As per this study, the median CD4 cell count at the time of diagnosis was 183/microL and 50.5% of adult population with a newly diagnosed HIV infection had a CD4 cell count that was <200. Kiertiburanakul S et al, based on data from multiple Asian countries, the overall median (IQR) CD4 cell count at ART initiation has shown an increasing trend over time from as low as 115cells/mm 3 in 2008 to a peak of 302cells/mm 3 after 2011 (p for trend 0.002). 22 But the lower mean CD4 count of the current study, compared to this study, in 2017 shows the high likelihood of regional variations within a nation. But in contrast to above study, Siedner MJ et al, in their recent meta-analysis reported a mean estimated CD4 count as 251cells/microL at presentation and 152cells/microL at ART initiation in the year 2002, which had shown no significant increase by the year 2013. 23 This indicates, unless organized efforts are made, transition in the sociodemographic profile of population and increased awareness levels may not translate into an early diagnosis of HIV infections.
In the current study, the factors which had shown a positive association with low CD4 count (<200) were male gender, poor educational status, working for population, single/divorced, people with more sexual partners and people with poor knowledge regarding HIV/AIDS. But none of the associations were statistically significant. In a study by Mutimura E et al, factors associated with a higher odds of advanced HIV disease at ART initiation were male sex and older age. 20 As per the study by Kiertiburanakul S et 24, 25 Program-level factors associated with low cohort median CD4 cell count included urban setting (adjusted odds ratio (AOR) 2.1, 95% confidence interval (CI) 1.3-3.3), lower provider-to-patient ratio (AOR 2.2, 95% CI 1.3-4.0), no PMTCT program (AOR 3.6; 95% CI 1.0-12.8), outreach services for ART patients only vs both pre-ART and ART patients (AOR 2.4, 95% CI 1.5-3.9), fewer vs more adherence support services (AOR 1.6, 95% CI 1.0-2.5) and smaller cohort size (AOR 2.5, 95% CI 1.4-4.5). Contextual-level factors associated with low cohort median CD4 cell count included initiating ART in areas where a lower proportion of the population heard of AIDS, tested for HIV recently, and a higher proportion believed limiting themselves to one HIV-uninfected sexual partner reduces HIV risk.
As per the study findings, the mean CD4 count was very low and almost 1 in 2 newly diagnosed subjects had CD4 count <200. Majority of the subjects sought diagnostic services after the onset of symptomatic disease attributed to AIDS or AIDs defining illness. The proportion of subjects seeking voluntary counseling and testing services when they are apparently healthy is negligible in this study population, in spite intense IEC activities by the government. Poor knowledge regarding the nature of the disease, preventive measures, diagnosis and treatment facilities available are responsible for the delay in utilization of voluntary screening services. The study findings pave the way for further large-scale studies to study the status and long-term impact of the CD4 count at initiation of HAART. Population-specific IEC interventions, considering the heterogeneous nature of Indian population, the differences in the educational, socio-economic and cultural aspects have to be designed and implemented.
The key limitation of this study was the inadequacy of sample size to perform multivariate analysis to rule of the role of confounding. Even the lack of statistical significance of many associations observed in the study could be attributed to chance, due to lower sample size. The generalizability of study findings to other population groups in India is limited.
CONCLUSION
At the time of HIV diagnosis almost half of the newly diagnosed patients had Cd4 count less than 200. This pattern indicates a clear need for enhanced educational efforts regarding the importance of early HIV testing for at-risk individuals. This early diagnosis could reduce HIV transmission as well as improve the prognosis for patients receiving HAART. The lack of statistical significance of many associations observed in the study could be attributed to lower sample size.
